Reducing the burden of diabetes treatment: A review of low-cost oral hypoglycemic medications.
Sign Up to like & getrecommendations! Published in 2020 at "Current diabetes reviews"
DOI: 10.2174/1573399816666200206112318
Abstract: BACKGROUND The vast majority of individuals diagnosed with diabetes are low/middle income and may have access to only three of the 11 oral hypoglycemic medications (OHMs) due to cost: metformin intermediate release (IR) or extended… read more here.
Keywords: pioglitazone; hypoglycemic medications; low cost; oral hypoglycemic ... See more keywords